Akoya Biosciences
Stock Forecast, Prediction & Price Target
Akoya Biosciences (AKYA) stock Price Target by analysts
$4
Potential upside: 210.10%
Akoya Biosciences price prediction
What is Akoya Biosciences stock analysts` prediction?
Akoya Biosciences stock forecast: Based on 1 Wall Street analysts` predicted price targets for Akoya Biosciences in the last 3 months, the avarage price target is $4, with a high forecast of $NaN. The average price target represents a 210.10% change from the last price of $1.29.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Akoya Biosciences stock Price Target by analysts
Full breakdown of analysts given Akoya Biosciences price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Dave Westenberg Piper Sandler | 0% 0/1 | 11 months ago | $4 210.10% upside | $2.32 | StreetInsider | Previous targets (0) |
Tejas Savant Morgan Stanley | 0% 0/2 | about 1 year ago | $3 132.57% upside | $2.01 | StreetInsider | Previous targets (1) |
Bill Bonello Craig-Hallum | 0% 0/1 | over 1 year ago | $7.5 481.44% upside | $2.23 | TheFly | Previous targets (0) |
Tejas Savant Morgan Stanley | 0% 0/2 | over 1 year ago | $4 210.10% upside | $2.15 | StreetInsider | Previous targets (1) |
Kyle Mikson Canaccord Genuity | 0% 0/1 | over 1 year ago | $6 365.15% upside | $4.12 | StreetInsider | Previous targets (0) |
Mark Massaro BTIG | 0% 0/1 | over 1 year ago | $6 365.15% upside | $4.12 | StreetInsider | Previous targets (0) |
David Westenberg Piper Sandler | 0% 0/1 | about 3 years ago | $17 1217.93% upside | $13.34 | TheFly | Previous targets (0) |
Akoya Biosciences Financial Estimates
Akoya Biosciences Revenue Estimates
Akoya Biosciences EBITDA Estimates
Akoya Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $54.91M N/A | $74.85M 36.31% | $96.63M 29.08% | Avg: $124.30M Low: $120.17M High: $131.16M avg. 28.63% | Avg: $147.47M Low: $140.67M High: $154.32M avg. 18.64% | Avg: $154.4M Low: $147.27M High: $161.57M avg. 4.69% | Avg: $171.5M Low: $163.58M High: $179.46M avg. 11.07% |
Net Income
% change YoY
| $-42.93M N/A | $-70.64M -64.53% | $-63.32M 10.35% | Avg: $-35.77M Low: $-41.76M High: $-21.32M avg. 43.50% | Avg: $-22.23M Low: $-28.88M High: $-5.77M avg. 37.84% | Avg: $-15.10M Low: $-16.01M High: $-14.20M avg. 32.04% | Avg: $-8.44M Low: $-8.95M High: $-7.93M avg. 44.11% |
EBITDA
% change YoY
| $-32.90M N/A | $-59.33M -80.29% | $-45.63M 23.09% | Avg: $-57.57M Low: $-60.75M High: $-55.66M avg. -26.16% | Avg: $-68.30M Low: $-71.47M High: $-65.15M avg. -18.64% | Avg: $-71.51M Low: $-74.83M High: $-68.21M avg. -4.69% | Avg: $-79.43M Low: $-83.12M High: $-75.76M avg. -11.07% |
EPS
% change YoY
| -$1.15 N/A | -$1.87 -62.60% | -$1.43 23.52% | Avg: -$0.68 Low: -$0.94 High: -$0.48 avg. 52.14% | Avg: -$0.36 Low: -$0.65 High: -$0.13 avg. 47.09% | Avg: -$0.34 Low: -$0.36 High: -$0.32 avg. 6.07% | Avg: -$0.19 Low: -$0.2 High: -$0.18 avg. 44.11% |
Operating Expenses
% change YoY
| $71.44M N/A | $109.59M 53.40% | $104.27M -4.86% | Avg: $100.29M Low: $96.96M High: $105.83M avg. -3.80% | Avg: $118.99M Low: $113.50M High: $124.52M avg. 18.64% | Avg: $124.58M Low: $118.83M High: $130.37M avg. 4.69% | Avg: $138.38M Low: $131.99M High: $144.80M avg. 11.07% |
FAQ
What is Akoya Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 39.38% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -41.76M, average is -35.77M and high is -21.32M.
What is Akoya Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 15.76% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $120.17M, average is $124.30M and high is $131.16M.
What is Akoya Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 37.36% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$0.94, average is -$0.68 and high is $-0.48.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Akoya Biosciences stock. The most successful analyst is Dave Westenberg.